Final closure of the Blackham Coliseum monoclonal antibody treatment site
[ad_1]
Louisiana’s monoclonal antibody treatment sites will temporarily close at various times during the holidays, but two sites will close permanently.
Lafayette’s Blackham Coliseum site will cease operations on December 15 and the Big Lots site in Thibodaux on December 30.
Other sites are closing for the Christmas holidays. The following locations will be closed on December 24 and reopen at 7 a.m. on December 26:
Westwego: Segnette field; south of the John Alario event center
Houma: Municipal community center of Houma
Thibodaux: Grands Lots (final closure on December 23)
Natchitoches: parking lot at the Troy Mayeaux ball field (in the Natchitoches Est recreation complex)
Shreveport: Sci-port Discovery Center mobile unit
Amite: Florida Parishes Arena
The following sites will close on December 24 and reopen at 7 a.m. on December 27:
Baton Rouge: Baton Rouge General Mid-City
Clinton: Clinton Alternative Learning Center
Acadiana: Rayne Civic Center
All sites will close at 2 p.m. on December 30 for the New Years holiday and reopen at 7 a.m. on January 2.
All monoclonal antibody sites are currently open 7 days a week from 8 a.m. to 6 p.m.
Learn more about treatment with monoclonal antibodies:
Monoclonal antibodies are artificial antibodies produced in the laboratory that can mimic the response of the human immune system to infection. MAbs are designed to block viral uptake and entry into human cells, thereby neutralizing the virus that causes COVID-19.
Patients should be referred by their doctor or other healthcare professional to a facility that offers mAb treatment, such as a hospital or infusion center. Walk-in visits are also accepted at new community sites; however, walk-in patients must have a positive COVID-19 viral test.
Patients with a positive COVID-19 viral test should speak with their healthcare provider to determine if they are eligible for mAb treatment and to discuss potential benefits and side effects.
Monoclonal antibody treatments can be used for the treatment of mild to moderate COVID-19 in adults and pediatric patients who are within 10 days of the onset of their symptoms, at least 12 years of age or older and weighing less 40 kilograms (88 pounds) and are at high risk of progressing to severe COVID-19 and / or hospitalization.
The federal government has developed a national map that displays the locations of therapeutic monoclonal antibody shipments under the authority of the FDA, EUA, in recent weeks. The scalable card is at https://protect-public.hhs.gov/pages/therapeutics-distribution.
A call center is also available to answer questions and provide information about therapeutic monoclonal antibody treatments at 1-877-332-6585 (in English); 1-877-366-0310 (Spanish language).
————————————————– ———-
Keep in touch with us anytime, anywhere.
To reach the newsroom or report a typo / correction, click HERE.
Sign up for newsletters sent by email to your inbox. Select from these options: Latest News, Evening News Headlines, Latest COVID-19 Headlines, Morning News Headlines, Special Offers
[ad_2]
